Influence of human immunodeficiency virus infection on cell-mediated immunity in chronic D hepatitis

J Infect Dis. 1991 Jun;163(6):1351-3. doi: 10.1093/infdis/163.6.1351.

Abstract

To determine whether the abnormalities of cell-mediated immunity described in chronic D hepatitis are associated with hepatitis D virus (HDV) infection or concomitant human immunodeficiency virus (HIV) infection, serologic and tissue hepatitis B virus (HBV) and HDV markers and T lymphocyte subsets were studied in serum samples from 38 patients with chronic D hepatitis, 26 of whom had HIV infection. Patients with chronic D hepatitis and HIV infection had significantly lower peripheral blood T4:T8 ratios resulting from a significant increase in T8+ (suppressor/cytotoxic) cells, while numbers of T lymphocyte subsets were normal in cases with chronic D hepatitis only. HIV+ patients showed an increase in HBV replication (identified by hepatitis B core antigen in liver and hepatitis B e antigen and HBV DNA in serum) and in HDV replication (tissue D antigen and HDV RNA) without evidence of more active liver disease. Probably the immunologic disturbances detected in chronic D hepatitis are secondary to HIV infection, do not contribute to the pathogenesis of liver injury, and are associated with increased viral B and D replication.

MeSH terms

  • Adolescent
  • Adult
  • CD4-Positive T-Lymphocytes
  • Chronic Disease
  • DNA, Viral / blood
  • Female
  • HIV Antibodies / blood
  • HIV Infections / complications*
  • HIV Infections / immunology
  • Hepatitis Antibodies / blood
  • Hepatitis B / complications
  • Hepatitis B / immunology
  • Hepatitis B Surface Antigens / blood
  • Hepatitis B e Antigens / blood
  • Hepatitis B virus / genetics
  • Hepatitis B virus / immunology
  • Hepatitis D / complications
  • Hepatitis D / immunology*
  • Hepatitis Delta Virus / immunology
  • Humans
  • Immunity, Cellular
  • Leukocyte Count
  • Lymphocytes
  • Male
  • RNA, Viral / blood
  • Substance Abuse, Intravenous / complications
  • T-Lymphocytes
  • T-Lymphocytes, Regulatory

Substances

  • DNA, Viral
  • HIV Antibodies
  • Hepatitis Antibodies
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • RNA, Viral